| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.65▼ | 9.05▼ | 9.13▼ | 8.85▼ | 9.99▼ |
| MA10 | 8.84▼ | 9.16▼ | 9.09▼ | 9.68▼ | 10.76▼ |
| MA20 | 9.13▼ | 9.07▼ | 9.09▼ | 10.36▼ | N/A |
| MA50 | 9.14▼ | 9.47▼ | 9.83▼ | N/A | N/A |
| MA100 | 9.63▼ | 10.34▼ | 10.33▼ | N/A | N/A |
| MA200 | 10.38▼ | 10.41▼ | 11.04▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.082▼ | -0.016▼ | 0.025▲ | N/A | N/A |
| RSI | 35.890▼ | 35.806▼ | 37.733▼ | N/A | N/A |
| STOCH | 14.451▼ | 46.237 | 61.248 | 10.199▼ | N/A |
| WILL %R | -81.513▼ | -83.704▼ | -83.704▼ | -88.916▼ | N/A |
| CCI | -138.552▼ | -237.965▼ | -99.615 | -92.521 | N/A |
|
Tuesday, September 03, 2019 08:23 PM
(MENAFN - GlobeNewsWire - Nasdaq) CAMBRIDGE, Mass., Sept.03, 2019(GLOBE NEWSWIRE) --Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives ...
|
|
Monday, September 02, 2019 05:00 PM
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically ...
|
|
Monday, August 19, 2019 05:15 AM
Fulcrum Therapeutics (NASDAQ:FULC) initiates a Phase 2b clinical trial, ReDUX4, evaluating losmapimod in patients with facioscapulohumeral muscular dystrophy (FSHD), a inherited disorder characterized ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/19 | 9.00 | 9.60 | 8.23 | 8.68 | 44,200 |
| 20/09/19 | 8.56 | 9.905 | 8.56 | 8.67 | 341,800 |
| 19/09/19 | 9.14 | 9.14 | 8.40 | 8.55 | 51,800 |
| 18/09/19 | 9.64 | 9.793 | 8.72 | 8.89 | 34,500 |
| 17/09/19 | 9.18 | 9.98 | 8.91 | 9.45 | 21,200 |
| 16/09/19 | 9.88 | 9.88 | 8.70 | 9.13 | 43,900 |
| 13/09/19 | 10.95 | 11.00 | 9.75 | 10.00 | 21,800 |
| 12/09/19 | 11.50 | 12.05 | 10.41 | 10.85 | 20,600 |
| 11/09/19 | 11.02 | 11.95 | 10.35 | 11.41 | 38,300 |
| 10/09/19 | 11.45 | 11.645 | 10.785 | 11.20 | 63,200 |
|
|
||||
|
|
||||
|
|